CEOs and Presidents: Learn why the rapidly growing accountability of biopharmaceutical CEOs and presidents affects you and your organization

KU Bioscience Biopharmaceutical Breakfast Program with Thomas Feyerabend
Friday, Sept. 14, 2012
7:15 a.m. – Complimentary Breakfast, Coffee and Registration
7:30–9:00 a.m. – Presentation
BEST Room 329, KU Edwards Campus, Overland Park, Kan.   

Catastrophic plant shutdowns and closures have recently occurred at major pharmaceutical corporations, resulting in huge FDA fines, remediation costs, loss of revenue, loss of market share and shortages of vital drugs. These shut downs cause us all to look closer at our own operations.

The KU Bioscience Biopharmaceutical Breakfast Program will feature the analysis and refreshing insight of biopharmaceutical industry thought leader Thomas Feyerabend, president and CEO of MANAGEX Consulting. RSVP today for this engaging morning that will challenge the way you think about achieving sustained regulatory compliance and maximizing business performance. There is no charge to attend. Come and discover the new role you must take in protecting the future of your organization.

At this program, you will:

• Learn why catastrophic compliance failures have occurred and how simple it is to completely prevent them from happening to you with negligible cost to your business.
• Discover how you can achieve remarkable growth in your top- and bottom-line performance within the next two to three years without a merger or acquisition.
• Explore how you can create a stimulating and dynamic culture for your organization.
• Examine how you can develop your personnel so that they can develop your business.

Every company can benefit from this program. RSVP here and find out how. Visit our website for more information.

Sponsored by KansasBio and KU Bioscience Continuing Education.